Tus kws kho mob
Furoscix® (furosemide) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 01, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1411 - 1420 ntawm 3685
Tus kws kho mob
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Commercial
Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Urinary Incontinence - Commercial
Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024
Tus kws kho mob
Tezspire® (tezepelumab-ekko) - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Gabapentin ER (extended-release) - Medicaid
Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Lyrica and Savella - Medicaid
Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
QP56-23 Provider Press: Q2 2023
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 28, 2023
Tus kws kho mob
QP57-23 Reimbursement Update
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 28, 2023
Tus kws kho mob
QP58-23 Value Code Format Requirements for Minnesota Health Care Programs
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 28, 2023
Tus kws kho mob
QP51-23 Commercial Pharmacy Benefit Exclusion for Aponvie™, Iheezo™, Omisirge®, and Qalsody™
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 14, 2023